TCL Archive Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside April 28, 2000
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies May 22, 2009